{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:46:57Z","timestamp":1791424017198,"version":"4.3.3"},"reference-count":44,"publisher":"American Society for Clinical Investigation","issue":"15","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK112921,DK113487,DK020579,TR002065,TR000448,TR002345"],"award-info":[{"award-number":["DK112921,DK113487,DK020579,TR002065,TR000448,TR002345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Wolfram syndrome is a rare ER disorder characterized by insulin-dependent diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration. Although there is no treatment for Wolfram syndrome, preclinical studies in cell and rodent models suggest that therapeutic strategies targeting ER calcium homeostasis, including dantrolene sodium, may be beneficial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Based on results from preclinical studies on dantrolene sodium and ongoing longitudinal studies, we assembled what we believe is the first-ever clinical trial in pediatric and adult Wolfram syndrome patients with an open-label phase Ib\/IIa trial design. The primary objective was to assess the safety and tolerability of dantrolene sodium in adult and pediatric Wolfram syndrome patients. Secondary objectives were to evaluate the efficacy of dantrolene sodium on residual pancreatic \u03b2 cell functions, visual acuity, quality-of-life measures related to vision, and neurological functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Dantrolene sodium was well tolerated by Wolfram syndrome patients. Overall, \u03b2 cell functions were not significantly improved, but there was a significant correlation between baseline \u03b2 cell functions and change in \u03b2 cell responsiveness (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      ,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.004) after 6-month dantrolene therapy. Visual acuity and neurological functions were not improved by 6-month dantrolene sodium. Markers of inflammatory cytokines and oxidative stress, such as IFN-\u03b3, IL-1\u03b2, TNF-\u03b1, and isoprostane, were elevated in subjects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>This study justifies further investigation into using dantrolene sodium and other small molecules targeting the ER for treatment of Wolfram syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>ClinicalTrials.gov identifier NCT02829268<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING<\/jats:title>\n                    <jats:p>NIH\/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK112921, DK113487, DK020579), NIH\/National Center for Advancing Translational Sciences (NCATS) (TR002065, TR000448), NIH training grant (F30DK111070), Silberman Fund, Ellie White Foundation, Snow Foundation, Unravel Wolfram Syndrome Fund, Stowe Fund, Eye Hope Foundation, Feiock Fund, Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from NIH\/NCATS, Bursky Center for Human Immunology &amp; Immunotherapy Programs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1172\/jci.insight.145188","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T12:02:25Z","timestamp":1624968145000},"source":"Crossref","is-referenced-by-count":36,"title":["A phase Ib\/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome"],"prefix":"10.1172","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-0758","authenticated-orcid":true,"given":"Damien","family":"Abreu","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine,"},{"name":"Medical Scientist Training Program,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-9341","authenticated-orcid":true,"given":"Stephen I.","family":"Stone","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3679-7707","authenticated-orcid":true,"given":"Toni S.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-8640","authenticated-orcid":true,"given":"Robert C.","family":"Bucelli","sequence":"additional","affiliation":[{"name":"Department of Neurology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Center for Clinical Studies,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Hurst","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris M.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Kries","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinyere","family":"Onwumere","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Gu","sequence":"additional","affiliation":[{"name":"Division of Biostatistics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hoekel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology & Visual Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Tychsen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology & Visual Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Van Stavern","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology & Visual Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"White","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2370-4479","authenticated-orcid":true,"given":"Bess A.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7549-0698","authenticated-orcid":true,"given":"Tamara","family":"Hershey","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry and Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-6293","authenticated-orcid":true,"given":"Fumihiko","family":"Urano","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine,"},{"name":"Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/2441"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0702-6"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92473-6"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1809"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39678"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.09.007"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1519"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1421055111"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-0408-5"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600620619"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.43.26965"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1021\/bi001502s"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.118.4.355"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516643600"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.4103\/2277-9175.210660","article-title":"The effect of a single dose dantrolene in patients with vasospasm following aneurysmal subarachnoid hemorrhage","volume":"6","author":"Sabouri","year":"2017","journal-title":"Adv Biomed Res"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-6-81","article-title":"Dantrolene is neuroprotective in Huntington\u2019s disease transgenic mouse model","volume":"6","author":"Chen","year":"2011","journal-title":"Mol Neurodegener"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2009.034.12.1443434"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0660-09.2009"},{"issue":"9","key":"B19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/1871527317666180619162649","article-title":"Dantrolene: from malignant hyperthermia to Alzheimer\u2019s disease","volume":"18","author":"Shi","year":"2018","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"5","key":"B20","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000374","article-title":"Calcium dysregulation in Alzheimer\u2019s disease: a target for new drug development","volume":"7","author":"Wang","year":"2017","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1965"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-64","article-title":"Phenotypic characteristics of early Wolfram syndrome","volume":"8","author":"Marshall","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040604"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-64"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/014107688607900507"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.10.005"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.11.037"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13960"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0871"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-7-89","article-title":"Reliability and validity of the Wolfram unified rating scale (WURS)","volume":"7","author":"Nguyen","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"3\u20134","key":"B31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/hmg\/ddab040","article-title":"Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation","volume":"30","author":"Panfili","year":"2021","journal-title":"Hum Mol Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.07.005"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1782"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.09.030"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.375"},{"key":"B36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0076-6879(07)33006-1","article-title":"Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress","volume":"433","author":"Milne","year":"2007","journal-title":"Methods Enzymol"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1177\/11772719211006666","article-title":"Cytokine profiling in plasma from patients with brain tumors versus healthy individuals using 2 different multiplex immunoassay platforms","volume":"16","author":"Bender","year":"2021","journal-title":"Biomark Insights"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107618"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.07.011"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1038\/srep21167","article-title":"Neuroimaging evidence of deficient axon myelination in Wolfram syndrome","volume":"6","author":"Lugar","year":"2016","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2014.07.162"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.5.733"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(87)91056-6"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-200012150-00008"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/145188\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:46:24Z","timestamp":1779147984000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/145188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":44,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,8,9]]},"published-print":{"date-parts":[[2021,8,9]]}},"alternative-id":["10.1172\/jci.insight.145188"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.145188","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.07.20208694","asserted-by":"object"}]},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"article-number":"e145188"}}